In today’s briefing:
- Japan Weekly | Yokohama Rubber, Mercari
- China Healthcare Weekly (Feb.24) – No. 1 Central Document, 8th National VBP, TCM Formula Granules
- GEM Weekly (24 Feb 2023): South Korean Rates; Pinduoduo, JD.com, NIO, TSMC
Japan Weekly | Yokohama Rubber, Mercari
- Incoming BoJ Governor Kazuo Ueda told parliament that he was in no rush to end the bank’s low interest rate policy.
- Meanwhile, consumer prices rose 4.2% in January, a level not seen since 1981.
- Japanese stocks ended the week down 0.2%. Tech stocks were buoyed by Advantest (+7%) and Nikon (+5%)
China Healthcare Weekly (Feb.24) – No. 1 Central Document, 8th National VBP, TCM Formula Granules
- China unveiled the “No. 1 central document”, providing a good opportunity for domestic healthcare enterprises to develop rural medical market – Its market size cannot be ignored.
- The 8th national VBP has been officially launched last week. Pfizer is the most affected of all foreign big pharma, which would have certain impact on its China business.
- We have noticed that the unified medical insurance code of traditional Chinese medicine (TCM) formula granules is accelerating, which seems to be paving the way for the future VBP.
GEM Weekly (24 Feb 2023): South Korean Rates; Pinduoduo, JD.com, NIO, TSMC
- The Global Emerging Markets weekly provides a summary of the key news and related developments impacting the largest countries and constituents of the Global Emerging Markets equity indices.
- Macro data points: South Korean exports, imports, PPI, and policy rates.
- Companies mentioned:Pinduoduo (PDD US), JD.com Inc. (9618 HK), NIO Inc (9866 HK), Taiwan Semiconductor (TSMC) (2330 TT)
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
